Thrombosis and Cancer
Editat de Gilles Lugassy, Anna Falanga, Ajay K Kakkar, Frederick R. Ricklesen Limba Engleză Hardback – 23 feb 2004
This text provides comprehensive and timely coverage of the current knowledge of cancer-associated thrombosis, its pathogenesis, clinical features, prevention, and therapy. It specifically addresses the relationship between hemostatic systems and cancer, thus providing a unique and much needed focus. All of the contributors are acknowledged specialists in their fields and have experience conducting large clinical trials in oncology and thrombosis. Their discussions cover all aspects of the topic, from long-term complications to cancer surgery.
With input from specialists in a range of disciplines including hematology, pharmacology, and surgery, this thorough text will be of interest to general practitioners, internists, oncologists, hematologists, and all physicians involved in the management of cancer patients.
Preț: 892.09 lei
Preț vechi: 939.05 lei
-5% Nou
Puncte Express: 1338
Preț estimativ în valută:
170.73€ • 177.34$ • 141.81£
170.73€ • 177.34$ • 141.81£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781841842875
ISBN-10: 1841842877
Pagini: 240
Ilustrații: 50 b/w images and 20 tables
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.55 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
ISBN-10: 1841842877
Pagini: 240
Ilustrații: 50 b/w images and 20 tables
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.55 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
Public țintă
Professional ReferenceCuprins
Thrombosis and Cancer: A Short History of the Trousseau's Syndrome. Pathogenesis of Thrombosis in Cancer. Platelets and Cancer. The Role of Blood Clotting in Tumor Metastasis: A Case for Tissue Factor. The Fibrinolytic System in Cancer. Tumor Angiogenesis and Blood Coagulation. Risk of Cancer in Patients Presenting with Venous Thromboembolism. Thrombotic Complications of Overt Cancer. Systematic Microangiopathies in the Cancer Patient. Thrombophilia and Risk of Venous THromboembolism in Cancer. Long-Term Thrombotic Complications in Cancer-Treated Patients: The Problem of Recurrent Venous Thromboembolism. Prevention of Cancer-associated Thrombosis: An Overview. Thromboprophylaxis in Cancer Surgery. Catheter-related Arm-Vein Thrombosis in Patients with Cancer. Prevention and Treatment of Thrombosis in Cancer Patients. Antimalignant Properties of Antithrombotic Agents.
Recenzii
"…a well-written multiauthored book….It will be of interest to clinicians in many disciplines."
-New England Journal of Medicine
'...a well-written multiauthored book that will fulfil its stated purpose - "to provide comprehensive and timely coverage of our current knowledge of cancer-associated thrombosis". It will be of interest to clinicians in many disciplines.' - The New England Journal of Medicine
-New England Journal of Medicine
'...a well-written multiauthored book that will fulfil its stated purpose - "to provide comprehensive and timely coverage of our current knowledge of cancer-associated thrombosis". It will be of interest to clinicians in many disciplines.' - The New England Journal of Medicine
Notă biografică
Gilles Lugassy, Anna Falanga, Ajay K. Kakkar and Frederick R. Rickles
Descriere
This text provides comprehensive and timely coverage of the current knowledge of cancer-associated thrombosis, its pathogenesis, clinical features, prevention, and therapy. It specifically addresses the relationship between hemostatic systems and cancer, thus providing a unique and much needed focus. All of the contributors are acknowledged specialists in their fields and have experience conducting large clinical trials in oncology and thrombosis. Their discussions cover all aspects of the topic, from long-term complications to cancer surgery. It will be of interest to general practitioners, internists, oncologists, hematologists, and all physicians involved in the management of cancer patients.